Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Propoxyphene

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 80367 refers to a laboratory test specifically designed to measure the presence of propoxyphene, also known as dextropropoxyphene, in various biological samples such as meconium stool, urine, serum, or plasma. Propoxyphene is classified as an analgesic and antitussive medication, which was commonly used in combination with other pain relievers like aspirin or acetaminophen. It was marketed under brand names such as Darvon and Darvocet. However, it is important to note that propoxyphene has been removed from the market in the United States since November 2010 due to serious safety concerns, including the risk of fatal overdoses and cardiac arrhythmias associated with its use. The testing process involves obtaining a blood sample through a procedure known as venipuncture, which is separately reportable. For urine samples, collection can be done via random voiding or catheterization, while meconium stool is typically collected from a diaper. The analysis of these samples is conducted using advanced techniques such as quantitative high performance liquid chromatography-tandem mass spectrometry, which allows for precise measurement of the drug levels in the collected specimens.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The laboratory test coded as CPT® 80367 is indicated for the detection and quantification of propoxyphene in various biological samples. The specific indications for performing this test include:

  • Monitoring Drug Use This test may be utilized to monitor patients who have a history of propoxyphene use, particularly in cases of suspected misuse or overdose.
  • Forensic Analysis The test can be employed in forensic settings to determine the presence of propoxyphene in individuals involved in legal cases or investigations.
  • Clinical Assessment It may be indicated in clinical assessments where propoxyphene exposure is suspected, especially in cases of acute toxicity or overdose.

2. Procedure

The procedure for conducting the test associated with CPT® 80367 involves several key steps, which are detailed as follows:

  • Sample Collection The first step in the procedure is the collection of biological samples. For blood testing, a venipuncture is performed to obtain serum or plasma. This involves inserting a needle into a vein to draw blood, which is a separately reportable procedure. For urine testing, a sample can be collected through random voiding, where the patient provides a urine sample at will, or through catheterization, which involves inserting a catheter into the bladder to collect urine. Additionally, meconium stool samples are collected from a diaper, which is particularly relevant in pediatric cases.
  • Sample Preparation Once the samples are collected, they are prepared for analysis. This preparation may involve processes such as centrifugation of blood samples to separate serum or plasma from cellular components, as well as proper handling and storage of urine and meconium samples to ensure integrity before testing.
  • Testing Methodology The prepared samples are then subjected to quantitative high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). This sophisticated analytical technique allows for the precise measurement of propoxyphene levels in the samples, providing accurate results that are essential for clinical decision-making.

3. Post-Procedure

After the completion of the testing procedure for CPT® 80367, the samples are analyzed, and results are generated. The expected post-procedure care primarily involves the interpretation of the test results by qualified healthcare professionals. It is crucial to ensure that the results are communicated effectively to the relevant parties, such as the prescribing physician or the patient, as appropriate. Additionally, any necessary follow-up actions based on the test results should be determined, which may include further clinical evaluation or intervention if propoxyphene levels are found to be elevated or indicative of misuse. Proper documentation of the test results and any subsequent actions taken is also essential for compliance and continuity of care.

Short Descr DRUG SCREENING PROPOXYPHENE
Medium Descr DRUG SCREENING PROPOXYPHENE
Long Descr Propoxyphene
Status Code Not Valid for Medicare Purposes
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x)
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T2D - Other tests - other
MUE 1
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GZ Item or service expected to be denied as not reasonable and necessary
Date
Action
Notes
2015-01-01 Added Added
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"